Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.227 USD
-3.81%
Market Closed
Updated:
May 20, 2024
Sonoma Pharmaceuticals Inc
Other Long-Term Assets
|
Sonoma Pharmaceuticals Inc
Other Long-Term Assets Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Other Long-Term Assets
$1.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
1%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Long-Term Assets
$19.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Long-Term Assets
$5.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Long-Term Assets
$16.1B
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
12%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Long-Term Assets
$11.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Long-Term Assets
$10.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
16%
|
See Also
What is Sonoma Pharmaceuticals Inc's Other Long-Term Assets?
Other Long-Term Assets
1.4m
USD
1.4m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Other Long-Term Assets amounts to 1.4m USD.
What is Sonoma Pharmaceuticals Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
1%
1%
Over the last year, the Other Long-Term Assets growth was -28%. The average annual Other Long-Term Assets growth rates for Sonoma Pharmaceuticals Inc have been 14% over the past three years , -4% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
